Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials

BACKGROUND/AIMS: To evaluate the efficacy of antivascular endothelial growth factor (anti-VEGF) agents pretreatment before vitrectomy for patients with complicated proliferative diabetic retinopathy (PDR). METHODS: The PubMed, Embase and the Cochrane Central Register of Controlled Trials were search...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Ophthalmol
Hlavní autoři: Zhao, Xin-yu, Xia, Song, Chen, You-xin
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2018
Témata:
Clinical Science
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059039/
https://ncbi.nlm.nih.gov/pubmed/29246890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2017-311344
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky